PharmiWeb.com - Global Pharma News & Resources
07-Apr-2021

Glucosamine Market will grow at 5.2% CAGR, to be valued at US$ 1,091.2 Million by 2027

SEATTLE, April 07, 2021, (PHARMIWEB) — Overview:

Glucosamine is an amino sugar and is one of the mono-saccharides most produced by hydrolysis of the shellfish exoskeleton or the fermentation process of grains such as wheat and corn. There are various uses for the treatment of synthetic glucosamine. For instance, oral glucosamine is used as a dietary supplement for a variety of health conditions such as joint pain and arthritis. The most commonly marketed preparation of glucosamine include glucosamine sulfate, glucosamine hydrochloride, glucosamine chondroitin, and N-acetylglucosamine. Glucosamine is commonly used with chondroitin to treat symptomatic osteoarthritis of the knee in people.

The global glucosamine market is estimated to be valued around US$ 763.7 million in 2020 and is expected to register a CAGR of 5.20% over the forecast period (2020-2027).

Figure 1. Global Glucosamine Market Value (US$ Mn), 2016-2027

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4345

Global Glucosamine Market – Impact of Coronavirus (COVID-19)

Since the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries around the world and the World Health Organization has declared it a public health emergency. According to a World Health Organization report, exposure to coronavirus (COVID-19) has resulted in around 72.3 million infected people worldwide from December 14th, 2020.

Moreover, COVID-19 has affected almost every market in the world and has had an impact on the global glucosamine market in the following ways: by directly affecting production and demand; by creating disruption to distribution channels; and its financial impact on financial firms and markets. Supply chain and manufacturing operations in India, China and the U.S. have been disrupted due to nationwide lockdowns. While countries such as Saudi Arabia, the UAE, Egypt and others are facing problems regarding drug transportation from one place to another.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4345

Drivers:

Rising number of rheumatoid arthritis cases is expected to drive growth of the global glucosamine market over the forecast period. For instance, according to the U.S. National Library of Medicine’s report published in 2017, prevalence of rheumatoid arthritis across the globe was 43.3 % in 2017.

Moreover, major players are focusing on launch and approval of novel product which is expected to robust growth of the global glucosamine market over the forecast period. For instance, in 2016, TSI Group Co. Ltd. (TSI) launched GlucosaGreenDF, a novel non-shellfish glucosamine branded product line produced by a patent-pending direct fermentation technology, in compliance with international monographs such as USP and the European Pharmacopeia.

Regional Analysis:

North America is expected to witness significant growth in the global glucosamine market over the forecast period due to research and development activities by major players in the field of glucosamine. For instance, in August 2018, Carlson Lab launched a novel formulation of Carlson Glucosamine & Chondroitin with Methyl SulfonylMethane (MSM), which provides human bone nourishing nutrients in one supplement.

Market segmentation:

  • By Product Type: Powder, Tablets, Capsules, Liquid.
  • By Application: Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/glucosamine-market-3605

Figure 2. Global Glucosamine Market Share (%), By Region, 2020

Key Players:

Major players operating in the global glucosamine market such as Panvo Organics Pvt Ltd, Pharma Base S.A., Bio-gen Extracts Private Limited, TSI Health Sciences, Inc., CAPTEK Softgel International Inc., Cargill, Andra Medi Pharma Pvt. Ltd, CellMark Chemicals,  Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC), Wellable Marine Biotech Holding Limited, JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD.,  Zhejiang Shinfuda Marine Biotechnology Corp,  Atlina Life Sciences and Spectrum Chemical Manufacturing Corporation.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers and Restraints
    • Opportunities
    • Impact Analysis
    • Recent Product Launches and Approvals
    • Pipeline Analysis
    • Brand Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Epidemiology
    • Reimbursement Scenario
    • Acquisition
    • Market Trend
  4. Global Glucosamine Market – Impact of COVID-19 Pandemic
    • Economic Impact
    • Government Initiatives
    • COVID-19 Impact on Supply and Demand
  5. Global Glucosamine Market, By Product Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Powder
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Tablets
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Capsules
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Liquid
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Glucosamine Market, By Application, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Rheumatoid Arthritis
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Asthma
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Inflammatory Bowel Disease
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Glucosamine Market, By Distribution Channel, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospital Pharmacies
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Retail Pharmacies
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Online Pharmacies
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Glucosamine Market, By Region, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type , 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 07-Apr-2021